Given the small number of studies available that have assessed the role of eNOS expression and the release of nitric oxide in the development of COPD-associated PH, the potential usefulness of targeting the nitric oxide pathway, particularly inhaled therapies in the treatment of PH associated with COPD needs further attention. The gene discussed is NOS3; the disease is chronic obstructive pulmonary disease.